Photo credit: www.theguardian.com
Major Cuts to HIV and AIDS Funding Raise Alarm Across Africa
Sweeping notices of funding termination have recently been issued to organizations engaged in combating HIV and AIDS throughout Africa, raising significant concerns over a potential surge in related deaths, according to health officials and advocates.
The United States has formally announced a permanent cessation of funding for various HIV initiatives, a decision that has had immediate ramifications for essential services in multiple regions. Medical professionals have expressed worries that the cuts jeopardize programs that support vulnerable populations, including orphans, pregnant women, transgender individuals, and sex workers.
Predictions indicate that these funding reductions could result in up to 500,000 additional deaths in South Africa over the next decade, based on recent modelling studies. The imminent job losses are also significant, with thousands of healthcare workers facing unemployment in the forthcoming days.
The reductions include a staggering over 90% cut to the funding contracts managed by the U.S. Agency for International Development (USAID), along with an overarching reduction of $60 billion in overseas aid expenditures.
Reports indicate that termination notices have been dispatched not only to organizations in South Africa but also to counterparts in neighboring nations such as Malawi, Zambia, Tanzania, and Zimbabwe, and to partnerships with the United Nations Programme on HIV/AIDS (UNAIDS).
The Elizabeth Glaser Pediatric AIDS Foundation disclosed that it had received termination notices affecting three critical projects, which currently supply HIV treatment to over 350,000 individuals across Lesotho, Eswatini, and Tanzania. This group includes more than 10,000 pregnant women living with HIV, who rely on antiretroviral therapy to prevent transmission to their infants.
Dr. Lynne Mofenson, a senior advisor at the Foundation, characterized the decision as “a death sentence for mothers and children.”
Many initiatives were compelled to halt operations late January after the Trump administration initiated a 90-day review of foreign aid. A number of these programs received temporary exceptions to continue providing vital services, only to be ordered to cease permanently shortly after.
Particularly impacted are initiatives supported by the President’s Emergency Plan for AIDS Relief (PEPFAR), a program established by President George W. Bush in 2003. In South Africa, PEPFAR funding constitutes 17% of the national response to HIV, while in some other countries, this figure is considerably higher.
Prof. Linda-Gail Bekker, director of the Desmond Tutu HIV Centre at the University of Cape Town, expressed deep concern, stating, “It is not hyperbole to say that I predict a huge disaster.” Recent modelling suggests that a complete withdrawal of PEPFAR funding could lead to over 500,000 additional HIV-related deaths in South Africa alone.
The timing of these funding cuts is particularly troubling, as recent scientific advances, including long-acting injectable preventative drugs, had sparked hope in the HIV research community for potential breakthroughs in fighting the epidemic. In light of the funding cuts, Bekker warns that progress may very well reverse. With approximately 8 million individuals living with HIV in South Africa—the highest number globally—the stakes are significantly high.
Initially, it was anticipated that U.S. funding might focus its cuts on programs targeting marginalized groups such as the LGBTQ+ community due to past political trends. However, Bekker indicates that the funding retraction has been pervasive, affecting a broad spectrum of services intended for children, orphans, young women, and vulnerable communities.
Moreover, these cuts also disrupt important ongoing research, including trials for new HIV vaccines and prevention methods, Bekker highlights. U.S. funding has been pivotal in bridging gaps in government healthcare provisions, specifically in clinics where marginalized groups such as transgender individuals and sex workers could receive care without discrimination.
Kholi Buthelezi, the national coordinator at Sisonke, an organization advocating for sex workers, described the emotional toll, stating, “I’ve been having sleepless nights. This blow reminds us of the times before there was hope against HIV.”
In a recent press briefing, Buthelezi and other health advocates in South Africa implored the government to “step up” and address the void left by the withdrawal of U.S. support.
PEPFAR funds have traditionally been managed through USAID and the U.S. Centers for Disease Control and Prevention (CDC). While programs funded by the CDC have not yet faced shutdown orders, Dr. Kate Rees from the Anova Health Institute cautioned that it remains too soon to guarantee their stability.
A planned transition towards greater reliance on government funding for these initiatives over the next five years now seems abruptly disrupted. “Now, instead of a careful handover, we’re being pushed over a cliff edge,” Rees remarked.
As the impact of U.S. funding withdrawal becomes increasingly apparent, it is expected that the healthcare community will bear the burden across the board, affecting everyone who relies on or works within health services. Anova, facing its funding cut, announced that it would be forced to release more than 2,800 employees, including counselors and healthcare workers, leaving them with limited prospects for future employment.
Source
www.theguardian.com